Skip to main content

August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective

Leukemia, Oncology

Novel Agents Will Completely Change CLL Treatment

Leukemia, Oncology

Bendamustine Outperforms R-CHOP in NHL

Pediatric Cancer, Oncology

Crizotinib Effective in Aggressive Pediatric Tumors

Caroline Helwick

The Oncology Drug Pipeline Robust with Novel Agents

Caroline Helwick, Wayne Kuznar

Payers Collaborate with Providers to Adopt Oncology Pathways, New Care Delivery Models

Rhonda Greenapple, MSPH

Family History of Cancer/Genetic Counseling Often Lacking for Patients First Presenting with Malignancy

For Advanced GIST, Regorafenib Shows Robust Effect

Cancer Screening Is Cost-Effective, Saves Lives

Cancer Therapies in Short Supply Prompt a Response at the Federal Level

High OOP Costs for Medicare Patients with Cancer

Page 2 of 4
Results 11 - 20 of 33